Clinical Trials · NCT03511768

A Study of 18F-AlF-NOTA-octreotide PET/CT for Imaging Neuroendocrine Neoplasms

Name: A Study of 18F-AlF-NOTA-octreotide PET/CT for Imaging Neuroendocrine Neoplasms
Creator: Peptide Science Daily
License: https://clinicaltrials.gov/about-site/terms-conditions

UnknownPhase 1/Phase 2Octreotide

Phase: Phase 1/Phase 2
Recruitment status: Unknown
Sponsor: Xiangya Hospital of Central South University
Enrollment: 65
Start date: Jan 2018
Locations: 1 site, China
Primary endpoint: 18F-AlF-NOTA-octreotide PET/CT imaging of patients with Neuroendocrine Neoplasms

View Octreotide compound reference